贝珠替凡与依维莫司治疗晚期肾癌：来自 ESMO 2023 的 LITESPARK-005 试验评论

{"title":"贝珠替凡与依维莫司治疗晚期肾癌：来自 ESMO 2023 的 LITESPARK-005 试验评论","authors":"Shuchi Gulati, Primo Nery Lara","doi":"10.3233/kca-230024","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":508303,"journal":{"name":"Kidney Cancer","volume":"278 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Belzutifan versus Everolimus in Advanced Kidney Cancer: A Commentary on LITESPARK-005 Trial from ESMO 2023\",\"authors\":\"Shuchi Gulati, Primo Nery Lara\",\"doi\":\"10.3233/kca-230024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":508303,\"journal\":{\"name\":\"Kidney Cancer\",\"volume\":\"278 3\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kidney Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3233/kca-230024\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3233/kca-230024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}